Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)
about
The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic InfectionsModeling transportation of efavirenz: inference on possibility of mixed modes of transportation and kinetic solubility.Population Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.Long-Term Effect of Rifampicin-Based Anti-TB Regimen Coadministration on the Pharmacokinetic Parameters of Efavirenz and 8-Hydroxy-Efavirenz in Ethiopian Patients.Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.
P2860
Q26751038-6D4C2423-7C0D-4705-9205-FF5683A88921Q35691622-3EC024BD-B493-4679-B5C9-742E912BDE84Q38755666-DB5BB2C9-7D2E-41A1-9310-02E7BF7BDCD5Q40694902-2112B81A-CDD7-4DA2-8F8A-BFDC6F7EEAD4Q41333285-293BE0F6-9421-4DF6-83C6-6AF4B96964F0Q46460183-4D6EBB70-CE73-4CCE-A299-8893AD16AC60Q52330065-F3FC95FB-F1B9-453C-AF1E-66BADF624B70
P2860
Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@ast
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@en
type
label
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@ast
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@en
prefLabel
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@ast
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@en
P2093
P2860
P50
P1433
P1476
Plasma concentrations, efficac ...... 295-CIPRA KH001 CAMELIA trial)
@en
P2093
Anne E Goldfeld
Anne-Marie Taburet
Bunnet Dim
Chanroeun Hak
Chindamony Kim
Didier Laureillard
Khemarin Kim Lak
Laurence Borand
Monidarin Chou
Narom Prak
P2860
P304
P356
10.1371/JOURNAL.PONE.0090350
P407
P577
2014-03-07T00:00:00Z